HIF-2α-induced upregulation of CD36 promotes the development of ccRCC

Exp Cell Res. 2022 Dec 15;421(2):113389. doi: 10.1016/j.yexcr.2022.113389. Epub 2022 Oct 15.

Abstract

Clear cell renal cell carcinoma (ccRCC) is characterized by the abundance of lipid droplets and the activation of the hypoxia-inducible factor (HIF) signaling pathway. However, the lipid reprogramming induced by HIF signaling in ccRCC is not fully understood. In this study, we found that the fatty acid receptor CD36 was highly expressed in human ccRCC tissues and ccRCC cell lines. CD36 overexpression increased fatty acid uptake and lipid droplet formation, and enhanced the proliferation and migration of ccRCC cells in a DGAT1-dependent manner. In contrast, the disruption of endogenous CD36 showed the opposite effects. The upregulated expression of CD36 in ccRCC was associated with hypoxia and HIF-2α activation. Furthermore, we identified CD36 as a new target of the transcription factor HIF-2α. The knockdown of CD36 in ccRCC cells reduced lipid accumulation and also blocked the tumor-promoting effects induced by HIF-2α under hypoxia. Our findings suggest that hypoxia-dependent HIF-2α promotes the remodeling of lipid metabolism and the malignant phenotype of ccRCC via CD36, providing a certain theoretical basis for clarifying the mechanism of ccRCC.

Keywords: CD36; HIF-2α; Hypoxia; Lipid; ccRCC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Basic Helix-Loop-Helix Transcription Factors / genetics
  • Basic Helix-Loop-Helix Transcription Factors / metabolism
  • Carcinoma, Renal Cell* / pathology
  • Cell Line, Tumor
  • Fatty Acids
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Hypoxia / genetics
  • Kidney Neoplasms* / pathology
  • Lipids
  • Up-Regulation / genetics

Substances

  • Basic Helix-Loop-Helix Transcription Factors
  • Fatty Acids
  • Lipids
  • endothelial PAS domain-containing protein 1
  • CD36 protein, human